Sona Saira Ramasastry
Direktor/Vorstandsmitglied bei GLENMARK PHARMACEUTICALS LIMITED
Vermögen: 820 073 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Sona Saira Ramasastry
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 55 | |
Aspen Global Leadership Network
54
| Private Company | 54 | |
| Public Company | Biotechnology | 38 | |
| Public Company | Pharmaceuticals: Major | 26 | |
| Public Company | Pharmaceuticals: Major | 23 | |
| Public Company | Pharmaceuticals: Major | 21 | |
15
| Subsidiary | Biotechnology | 15 |
Elevian, Inc.
 Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA.
11
| Holding Company | Pharmaceuticals: Major | 11 |
| Public Company | Biotechnology | 10 | |
Wasserstein Perella & Co., Inc.
9
| Private Company | 9 | |
| Holding Company | Pharmaceuticals: Major | 6 | |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
| Public Company | Biotechnology | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sona Saira Ramasastry
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Founder Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member General Counsel Director/Board Member Chief Operating Officer Corporate Officer/Principal Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Analyst Private Equity Investor | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Chairman Corporate Officer/Principal Corporate Officer/Principal | |
Marcadia Biotech, Inc.
 Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Operating Officer Chief Executive Officer Corporate Officer/Principal | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| The University of Colorado | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Mumbai | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Glenmark Pharmaceuticals SA
 Glenmark Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals SA is a Swiss pharmaceutical company that entered the highly regulated and competitive market in 2004. The company is based in Neuchâtel, Switzerland. The company delivers high-quality products across the globe and has manufacturing facilities in Baddi. Glenmark Pharma is discovering advanced therapies for a new world and creating centers of excellence in dermatology, oncology, and more. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Human Resources Officer | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Glenmark Generics Ltd.
 Glenmark Generics Ltd. Pharmaceuticals: MajorHealth Technology Part of Glenmark Pharmaceuticals Ltd., Glenmark Generics Ltd. is an Indian company that manufactures and markets generic drugs. The company is based in Mumbai, India. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| Glenmark Holding SA | Director/Board Member Director/Board Member Director/Board Member | ||
| University of California | College/University | Corporate Officer/Principal President Undergraduate Degree | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| JUNO THERAPEUTICS INC | Biotechnology | Founder Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member Founder Director/Board Member | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
| ACELYRIN, INC. | Founder Director/Board Member | ||
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 43 |
| Indien | 3 |
| Schweiz | 3 |
| Irland | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 4 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 779 |
| Corporate Officer/Principal | 259 |
| Independent Dir/Board Member | 248 |
| Chief Executive Officer | 107 |
| President | 92 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| Ed Mathers Mathers | 47 |
| Robert More | 42 |
| Patrick Heron | 42 |
| Timothy Walbert | 40 |
| Vijayalakshmi R. Iyer | 38 |
| Milind Shripad Sarwate | 38 |
| George Scangos | 33 |
| Michael Grey | 32 |
| William Ringo | 32 |
| Robert Perez | 31 |
| Karen Smith | 29 |
| Russ I. Pillar | 29 |
| Vicki Sato | 28 |
| Laura Brege | 27 |
- Börse
- Insiders
- Sona Saira Ramasastry
- Unternehmensverbindungen